BAVENCIO: payments to doctors
Payments that named BAVENCIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.6M
- Providers
- 7,548
- Transactions
- 30,150
- Average per transaction
- $153
The per-transaction average — $153 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,548 providers the average total is $611, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| EMD Serono, Inc. | $2,443,862 | 53.0% |
| Pfizer | $2,092,064 | 45.4% |
| Merck Kgaa | $40,840 | 0.9% |
| Ares Trading SA | $15,495 | 0.3% |
| PBG Puerto RICO LLC | $6,214 | 0.1% |
| Pfizer Chile S.A. | $4,600 | 0.1% |
| Hospira, Inc. | $3,000 | 0.1% |
| Merck, S.l.u. | $2,250 | 0.0% |
| Pfizer Pharmaceuticals LLC | $479 | 0.0% |
| Array Biopharma Inc | $65 | 0.0% |